Publications by authors named "Haruka Yoshii"

Article Synopsis
  • * Researchers used various techniques, including immunohistochemistry and microarray analyses, to assess SIRT6 expression in OSCC compared to noncancerous tissues, finding higher levels in the cancerous tissues.
  • * Results suggest that increased SIRT6 expression is associated with older patients and shorter survival rates, indicating its potential as a prognostic marker and target for treatment in OSCC.
View Article and Find Full Text PDF

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m and cisplatin, total of 175 mg/m), cetuximab (initial dose of 400 mg/m with subsequent weekly doses of 250 mg/m intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor.

View Article and Find Full Text PDF

Cell-penetrating peptides are arginine- and lysine-rich cationic peptides that can readily enter cells not only by themselves but also carrying other macromolecular cargos. In fact, we have reported that polycationic polymer such as poly-l-lysine (PLL) and poly-l-arginine (PLA) translocate through negatively charged phospholipid liposome membranes. In this work, we made a comparative study of the interaction of PLL or PLA with lipid membranes consisting of negatively charged phospholipids to understand the role of basic amino acid residue (i.

View Article and Find Full Text PDF

Arginine-rich, cell-penetrating peptides (e.g., Tat-peptide, penetratin, and polyarginine) are used to carry therapeutic molecules such as oligonucleotides, DNA, peptides, and proteins across cell membranes.

View Article and Find Full Text PDF